SCHEMBL8200484

SCHEMBL8200484

CCOC(=O)[C@@]1(NC(=O)OC(C)(C)C)C[C@H]1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.38
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.34
HCRTR2 O43614 1/20 0.33
CTSL P07711 1/20 0.33
CPB2 Q96IY4 1/20 0.33
CACNA1H O95180 1/20 0.33
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5427004 1.00 KMT2A (0.39) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL2630591 0.87 KMT2A (0.40) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL10089091 0.85 KMT2A (0.37) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL13415252 0.85 KMT2A (0.37) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL15424510 0.84 MAPK1 (0.42) KMT2AALDH1A1MEN1MAPK1CACNA1H
SCHEMBL20629740 0.84 MAPK1 (0.42) KMT2AALDH1A1MEN1MAPK1CACNA1H
SCHEMBL15424518 0.84 MAPK1 (0.42) KMT2AALDH1A1MEN1MAPK1CACNA1H
SCHEMBL1433455 0.83 KMT2A (0.38) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL6051013 0.83 KMT2A (0.38) KMT2AALDH1A1MEN1TSHRMAPK1
SCHEMBL375218 0.83 KMT2A (0.38) KMT2AALDH1A1MEN1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813500-B1 Intermediates for the preparation of hepatitis C virus inhibitors BRISTOL MYERS SQUIBB CO (US) 2016-08-17 EP disclosed
EP-1863793-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-07-04 EP disclosed
WO-2008064066-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-29 WO disclosed